JWH-030: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:JWH-030}} | |||
== | == Overview == | ||
'''JWH-030''' is a synthetic [[cannabinoid]] that acts as a potent agonist at the [[cannabinoid receptor]]s. It is part of the [[naphthoylindole]] family of compounds, which are known for their ability to mimic the effects of [[tetrahydrocannabinol]] (THC), the primary psychoactive component of [[cannabis]]. | |||
JWH-030 | == Chemical Structure == | ||
[[File:JWH-030.svg|thumb|right|Chemical structure of JWH-030]] | |||
JWH-030 is chemically classified as a naphthoylindole, with the full chemical name being 1-butyl-3-(1-naphthoyl)indole. The structure consists of a naphthalene ring system attached to an indole core, with a butyl chain at the nitrogen atom of the indole. | |||
== | == Pharmacology == | ||
JWH-030 functions as a full agonist at both the [[CB1 receptor|CB1]] and [[CB2 receptor|CB2]] cannabinoid receptors. These receptors are part of the [[endocannabinoid system]], which plays a role in regulating various physiological processes including pain sensation, mood, and appetite. | |||
JWH-030 | === CB1 Receptor === | ||
The CB1 receptor is primarily located in the [[central nervous system]], and its activation by JWH-030 can lead to psychoactive effects similar to those produced by THC. | |||
== | === CB2 Receptor === | ||
The CB2 receptor is mainly found in the [[peripheral nervous system]] and [[immune system]]. Activation of CB2 receptors by JWH-030 is associated with anti-inflammatory effects and modulation of immune responses. | |||
== Legal Status == | |||
The legal status of JWH-030 varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of medical use. | |||
== | == Synthesis == | ||
JWH-030 is synthesized through a series of chemical reactions starting from indole and naphthoyl chloride. The process involves the formation of an amide bond between the indole nitrogen and the carbonyl carbon of the naphthoyl chloride, followed by the addition of a butyl group. | |||
== Potential Uses == | |||
While JWH-030 and other synthetic cannabinoids have been studied for their potential therapeutic effects, such as pain relief and anti-inflammatory properties, their use is limited due to safety concerns and the availability of safer alternatives. | |||
== | == Risks and Side Effects == | ||
The use of JWH-030 can lead to a range of side effects, including [[tachycardia]], [[anxiety]], [[paranoia]], and [[hallucinations]]. Long-term use may result in dependence and withdrawal symptoms. | |||
== Related Pages == | |||
* [[ | * [[Cannabinoid receptor]] | ||
* [[Synthetic cannabinoids]] | * [[Synthetic cannabinoids]] | ||
* [[ | * [[Endocannabinoid system]] | ||
* [[Tetrahydrocannabinol]] | |||
[[Category:Synthetic cannabinoids]] | [[Category:Synthetic cannabinoids]] | ||
Latest revision as of 03:58, 13 February 2025
Overview[edit]
JWH-030 is a synthetic cannabinoid that acts as a potent agonist at the cannabinoid receptors. It is part of the naphthoylindole family of compounds, which are known for their ability to mimic the effects of tetrahydrocannabinol (THC), the primary psychoactive component of cannabis.
Chemical Structure[edit]
JWH-030 is chemically classified as a naphthoylindole, with the full chemical name being 1-butyl-3-(1-naphthoyl)indole. The structure consists of a naphthalene ring system attached to an indole core, with a butyl chain at the nitrogen atom of the indole.
Pharmacology[edit]
JWH-030 functions as a full agonist at both the CB1 and CB2 cannabinoid receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes including pain sensation, mood, and appetite.
CB1 Receptor[edit]
The CB1 receptor is primarily located in the central nervous system, and its activation by JWH-030 can lead to psychoactive effects similar to those produced by THC.
CB2 Receptor[edit]
The CB2 receptor is mainly found in the peripheral nervous system and immune system. Activation of CB2 receptors by JWH-030 is associated with anti-inflammatory effects and modulation of immune responses.
Legal Status[edit]
The legal status of JWH-030 varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of medical use.
Synthesis[edit]
JWH-030 is synthesized through a series of chemical reactions starting from indole and naphthoyl chloride. The process involves the formation of an amide bond between the indole nitrogen and the carbonyl carbon of the naphthoyl chloride, followed by the addition of a butyl group.
Potential Uses[edit]
While JWH-030 and other synthetic cannabinoids have been studied for their potential therapeutic effects, such as pain relief and anti-inflammatory properties, their use is limited due to safety concerns and the availability of safer alternatives.
Risks and Side Effects[edit]
The use of JWH-030 can lead to a range of side effects, including tachycardia, anxiety, paranoia, and hallucinations. Long-term use may result in dependence and withdrawal symptoms.
